Private Trust Company’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.3K Buy
125
+40
+47% +$3.39K ﹤0.01% 2146
2026
Q1
$8.45K Hold
85
– – ﹤0.01% 2029
2025
Q4
$10.3K Buy
85
+28
+49% +$3.51K ﹤0.01% 1919
2025
Q3
$6.39K Buy
57
+41
+256% +$4.8K ﹤0.01% 2075
2025
Q2
$2.14K Buy
+16
New +$1.76K ﹤0.01% 2254
2024
Q1
– Sell
-79
Closed -$6.24K – 2361
2023
Q4
$6.24K Sell
79
-15
-16% -$905 ﹤0.01% 1835
2023
Q3
$5.15K Sell
94
-19
-17% -$1.37K ﹤0.01% 1867
2023
Q2
$9.49K Buy
113
+56
+98% +$4.29K ﹤0.01% 1641
2023
Q1
$4.32K Buy
+57
New +$3.94K ﹤0.01% 1889

Other funds holding TMDX

Private Trust Company's TMDX Position: Q2 2026 in Review

Private Trust Company increased its Transmedics (TMDX) stake by 47% in Q2 2026, buying an estimated $3.39K and bringing the position to 125 shares worth $8.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2146.

Private Trust Company first reported a position in TMDX in Q1 2023 and has held it in 9 quarters since. The position peaked at $10.3K in Q4 2025. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Private Trust Company held 125 shares of Transmedics worth $8.3K as of Q2 2026.
  • Private Trust Company bought 40 Transmedics shares in Q2 2026, an estimated $3.39K.
  • Transmedics made up ﹤0.01% of Private Trust Company's portfolio in Q2 2026, its #2146 holding.
  • Private Trust Company first reported a position in Transmedics in Q1 2023 and has held it in 9 quarters since.
  • Private Trust Company's Transmedics position peaked at $10.3K in Q4 2025.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Private Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.